Related Experiment Video

Updated: Apr 18, 2026

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

1.3K

Low NDFIP1-driven metabolic alterations in CD8 + T cells: implications for immune evasion and therapy resistance in

Jun Wan1, YiBo Zhou1, Dan Xie1

  • 1Department of Otolaryngology Head and Neck Surgery, Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital, 22 Xingsha Avenue, Changsha, 410100, Hunan, China.

Cancer Cell International
|April 17, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CD8 + T cellsHead and neck squamous cell carcinomaImmunotherapyNDFIP1Oxidative phosphorylation

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K

Related Experiment Videos

Last Updated: Apr 18, 2026

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

1.3K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

8.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.9K

Articles linked to this work by shared authors, journal, and citation graph.

Zscan4c activates endogenous retrovirus MERVL and cleavage embryo genes.

Nucleic acids research·2019

Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.

Cancer science·2019

MSI2-TGF-β/TGF-β R1/SMAD3 positive feedback regulation in glioblastoma.

Cancer chemotherapy and pharmacology·2019

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.

Molecular cancer·2019

Association between suicide and multiple sclerosis: An updated meta-analysis.

Multiple sclerosis and related disorders·2019

The Open Chromatin Landscape of Non-Small Cell Lung Carcinoma.

Cancer research·2019

Cold atmospheric plasma affects metabolic processes in malignant melanoma.

Cancer cell international·2026

NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models.

Cancer cell international·2026

Quantifying target antigen-dependent CAR T-cell performance against AML.

Cancer cell international·2026

The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential.

Cancer cell international·2026

CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions.

Cancer cell international·2026

Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics.

Cancer cell international·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us